Multiple Sclerosis Market To Reach USD 39.9 Billion By 2032, Report By DataHorizzon Research Fort Collins, Colorado, April 25, 2024 (GLOBE NEWSWIRE) -- Rise in cases of multiple sclerosis to trigger the need for vaccines and diagnosis. Multiple sclerosis (MS) is a condition characterized...

Multiple Sclerosis Drugs Market Worth $40.66 Bn at 7.1% CAGR; Industry Bigwigs Such as Novartis and Biogen to Focus on Introducing Cost-Effective MS Treatments: Fortune Business Insights™ Pune, Aug. 24, 2020 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is projected to reach USD 40.66 billion by 2027, exhibiting a CAGR of 7.1% during the forecast period. ...

Multiple Sclerosis Drugs Market to Hit USD 40.66 Bn by 2027; Promising Research into Developing Efficient MS Therapies to Prove Beneficial for the Market: Fortune Business Insights™ Pune, July 30, 2020 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is projected to reach USD 40.66 billion by 2027, exhibiting a CAGR of 7.1% during the forecast period. High...